AOD9604 is a modified peptide fragment (residues 176-191) of human growth hormone (HGH). It was originally developed as a potential anti-obesity therapeutic because it isolates the specific fat-burning effects of HGH.

Unlike full human growth hormone, AOD9604 is designed to not affect blood sugar, insulin levels, or cell proliferation (it does not stimulate IGF-1). Its primary mechanism involves stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the conversion of non-fat food sources into body fat). This makes it a subject of significant interest in research focused on fat loss, metabolic regulation, and body composition.

This 5mg vial of AOD9604 is provided in a lyophilized (freeze-dried) powder form, ensuring stability and potency. It is intended strictly for in-vitro laboratory research and educational purposes.

Key Research Applications:

• Studying lipolytic and anti-lipogenic pathways.

• Investigating metabolic regulation and fat oxidation.

• Exploring potential applications in cartilage and bone repair.

CAS Number: 221231-10-3

Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe

Storage: Store lyophilized powder at -20°C. Once reconstituted, store at 2°C – 8°C.